These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6750405)

  • 1. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.
    Fromtling RA; Shadomy HJ; Jacobson ES
    Mycopathologia; 1982 Jul; 79(1):23-9. PubMed ID: 6750405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.
    Chang YC; Cherniak R; Kozel TR; Granger DL; Morris LC; Weinhold LC; Kwon-Chung KJ
    Infect Immun; 1997 May; 65(5):1584-92. PubMed ID: 9125534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.
    Kwon-Chung KJ; Rhodes JC
    Infect Immun; 1986 Jan; 51(1):218-23. PubMed ID: 3079732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection.
    Wilder JA; Olson GK; Chang YC; Kwon-Chung KJ; Lipscomb MF
    Am J Respir Cell Mol Biol; 2002 Mar; 26(3):306-14. PubMed ID: 11867339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
    Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
    Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic response to capsule-deficient Cryptococcus neoformans.
    Farmer SG; Komorowski RA
    Arch Pathol; 1973 Dec; 96(6):383-7. PubMed ID: 4594090
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum.
    Steenbergen JN; Nosanchuk JD; Malliaris SD; Casadevall A
    Infect Immun; 2003 Sep; 71(9):4862-72. PubMed ID: 12933827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico.
    Fromtling RA; Abruzzo GK; Ruiz A
    Mycopathologia; 1989 Jun; 106(3):163-6. PubMed ID: 2682249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
    Upreti HB; Rawat DS; Das SK
    Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsule size of Cryptococcus neoformans: control and relationship to virulence.
    Dykstra MA; Friedman L; Murphy JW
    Infect Immun; 1977 Apr; 16(1):129-35. PubMed ID: 326665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cys
    Fan CL; Han LT; Jiang ST; Chang AN; Zhou ZY; Liu TB
    Fungal Genet Biol; 2019 Mar; 124():59-72. PubMed ID: 30630094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus neoformans: size range of infectious particles from aerosolized soil.
    Neilson JB; Fromtling RA; Bulmer GS
    Infect Immun; 1977 Sep; 17(3):634-8. PubMed ID: 332630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions to the strain-specific virulence of Cryptococcus neoformans. Animal experiments with two C. neoformans-strains isolated from bird manure. Preliminary report (author's transl)].
    Staib F; Mishra SK
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):81-5. PubMed ID: 1101575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine responses and accumulation of inflammatory cells in the lungs of mice infected with highly virulent Cryptococcus neoformans: effects of interleukin-12.
    Kawakami K; Shibuya K; Qureshi MH; Zhang T; Koguchi Y; Tohyama M; Xie Q; Naoe S; Saito A
    FEMS Immunol Med Microbiol; 1999 Sep; 25(4):391-402. PubMed ID: 10497871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome.
    Guo C; Chen M; Fa Z; Lu A; Fang W; Sun B; Chen C; Liao W; Meng G
    Microbes Infect; 2014 Oct; 16(10):845-54. PubMed ID: 25193031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice.
    Salkowski CA; Bartizal KF; Balish MJ; Balish E
    Infect Immun; 1987 Sep; 55(9):2000-5. PubMed ID: 3305359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.
    Kechichian TB; Shea J; Del Poeta M
    Infect Immun; 2007 Oct; 75(10):4792-8. PubMed ID: 17664261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the virulence of Cr. neoformans strains, of animal or telluric origin, against mice].
    Gargani G
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):365-83. PubMed ID: 334195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.